In the field of child health, addressing severe acute malnutrition is a critical challenge, especially in hospital settings. The F-75 Therapeutic Formula, developed by Nutriset, represents a significant advance in this field, following the guidelines of the World Health Organization (WHO). This article explores the features, target audience, and importance of the F-75 to humanitarian aid organizations.
Specific Features of Formula F-75
F-75 Therapeutic Formula is a therapeutic milk low in protein, fat and sodium, but rich in carbohydrates. Specifically designed for phase 1 of the treatment of severe acute malnutrition, its 75 Kcal/100ml composition is designed to stabilize patients, rather than to promote immediate weight gain. It is crucial in the recovery of metabolic functions and electrolyte balance in hospitalized children.
Target Audience: Children with Severe Acute Malnutrition
Formula F-75 is designed for children 6 months of age and older who suffer from severe acute malnutrition. These patients, often hospitalized with medical complications such as infections or liver failure, require specialized nutritional care.
Utility for Humanitarian Aid Organizations
For humanitarian aid organizations, Formula F-75 is an invaluable resource. In crisis situations, where severe acute malnutrition is prevalent, this formulation allows healthcare professionals to safely and effectively stabilize patients before progressing to later stages of nutritional treatment.
Benefits of Formula F-75
Safety and efficacy
Adapted to the needs of severely malnourished children, it provides essential nutrients without overloading their compromised metabolism.
Compliance with Global Guidelines
Developed in line with nutritionist specifications and WHO guidelines.
Ease of Use in Clinical Environments
Designed for use in nutritional rehabilitation centers under medical supervision.
Recommendations for use
It is crucial to understand that Formula F-75 should not be used as a regular diet for well-nourished children or replace breast milk. Exclusive breastfeeding is strongly recommended until 6 months of age and its continuation until 24 months.
Therapeutic Formula F-75 is an example of how science and nutritional innovation can save lives in critical situations of severe acute malnutrition. Its specific design for stabilization in the initial phase of treatment makes it an essential component in the arsenal of tools available to humanitarian aid organizations and healthcare professionals. By offering an adapted and safe solution, Formula F-75 excels in the mission of combating childhood malnutrition in challenging environments globally.
